Your browser doesn't support javascript.
loading
Non-Whipple Operations in the Management of Benign, Premalignant and Early Cancerous Duodenal Lesions.
Papalampros, Alexandros; Moris, Demetrios; Petrou, Athanasios; Dimitrokallis, Nikolaos; Karavokyros, Ioannis; Schizas, Dimitrios; Delladetsima, Ioanna; Pappas, Theodore N; Felekouras, Evangelos.
Afiliação
  • Papalampros A; First Department of Surgery, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Moris D; First Department of Surgery, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece dimmoris@yahoo.com.
  • Petrou A; Department of Surgery, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, U.S.A.
  • Dimitrokallis N; Nicosia Surgical Department, Division of Hepatobiliary Pancreatic Surgery, Nicosia General Hospital, Nicosia, Cyprus.
  • Karavokyros I; First Department of Surgery, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Schizas D; First Department of Surgery, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Delladetsima I; First Department of Surgery, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Pappas TN; Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Felekouras E; Department of Surgery, Duke University, Durham, NC, U.S.A.
Anticancer Res ; 37(3): 1443-1452, 2017 03.
Article em En | MEDLINE | ID: mdl-28314316
ABSTRACT

AIM:

We reviewed our 20-year experience with non-Whipple operations (pancreas-preserving duodenectomy and transduodenal ampullectomy) for the treatment of benign, premalignant or early-stage malignant duodenal lesions. PATIENTS AND

METHODS:

Twenty-four patients who underwent non-Whipple operations between January 1996 and December 2015 were identified from an institutional database and retrospectively analyzed.

RESULTS:

Between 1996 and 2015, 10 patients underwent pancreas-preserving duodenectomy and 14 patients underwent transduodenal ampullectomy. The mean follow-up was 25.8 months (range=6-54 months) and no patient was lost to follow-up. Eighteen patients had preoperative diagnosis of duodenal adenomatosis, three patients had preoperative diagnosis of duodenal adenocarcinoma, one had a bleeding polyp and two had localized inflammation. Average operative time was 145 min (range=127-168 min) for transduodenal ampullectomy and 183 min (range=173-200 min) for pancreas-preserving duodenectomy (p<0.05). The estimated blood loss for transduodenal ampullectomy was 85 vs. 125 ml for pancreas-preserving duodenectomy (p<0.05). Early postoperative complications were noted in 13 cases (54.17%). There were no postoperative (90-day) deaths observed in this series and there were no recurrences during follow-up for the patients operated on with neoplastic lesions.

CONCLUSION:

For carefully selected patients, transduodenal ampullectomy and pancreas-preserving duodenectomy may be used in place of the Whipple operation for benign and occasionally early-stage malignant (Tis and T1) duodenal and ampullary disease.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ampola Hepatopancreática / Neoplasias Duodenais Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ampola Hepatopancreática / Neoplasias Duodenais Idioma: En Ano de publicação: 2017 Tipo de documento: Article